| 产品名称： | JeKo-1 |
|---|---|
| 商品货号： | TS209439 |
| Organism： | Homo sapiens, human |
| Tissue： | peripheral blood, Mantle Cell Lymphoma |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Lymphoma |
| Age： | 78 |
| Gender： | female |
| Applications： | JeKo-1 cells are highly tumorigenic in SCID mice. Ref   Jeon, H.J., et al. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol. ;102(5):1323-1326 (1998 ). PubMed: 9753063xa0 |
| Storage Conditions： | liquid nitrogen vapor phase |
| Images： |  |
| Derivation： | The JeKo-1 Mantle cell lymphoma (MCL) cell line was established from peripheral blood mononuclear cells of a patient with a large cell variant of MCL showing leukemic conversion. |
| Clinical Data： | female The JeKo-1 Mantle cell lymphoma (MCL) cell line was established from peripheral blood mononuclear cells of a patient with a large cell variant of MCL showing leukemic conversion. |
| Antigen Expression： | CD3-, CD5+, CD10+, CD19+ (verified at ATCC) |
| Genes Expressed： | CD3-, CD5+, CD10+, CD19+ (verified at ATCC) |
| Comments： | The cells overexpress cyclin D1, Bcl-2, c-Myc and Rb proteins. Bcl-1/J(H) gene rearrangement was confirmed by polymerase chain reaction. JeKo-1 cells are highly tumorigenic in SCID mice. Ref
Jeon, H.J., et al. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol. ;102(5):1323-1326 (1998 ). PubMed: 9753063xa0JeKo-1 cells are negative for Epstein-Barr virus and express IgM, a B-cell phenotype.
|
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 x 104 to 4 X 104 viable cells/mL. Do not allow the cell concentration to reach 2.5 X 106 cells/mL. |
| Cryopreservation： | Freeze medium: 30% RPMI; 60% FBS; 10% DMSO Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Atmosphere: 5% CO2 in air recommended Temperature: 37°C |
| STR Profile： | Amelogenin:X CSF1PO:9,12 D13S317:8,9 D16S539:12 D5S818:10,13 D7S820:10,11 THO1:7 TPOX:8 vWA: 14 |
| Name of Depositor： | E Campo |
| References： | Salaverria I, et al. Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 91: 11-16, 2006. PubMed: 16434365 Camps, J., et al. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res. 30(8):923-934 (2006). PubMed: 16448697 Jeon, H.J., et al. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol. ;102(5):1323-1326 (1998 ). PubMed: 9753063 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | JeKo-1 |
|---|---|
| 商品货号： | TS209439 |
| Organism： | Homo sapiens, human |
| Tissue： | peripheral blood, Mantle Cell Lymphoma |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Lymphoma |
| Age： | 78 |
| Gender： | female |
| Applications： | JeKo-1 cells are highly tumorigenic in SCID mice. Ref Jeon, H.J., et al. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol. ;102(5):1323-1326 (1998 ). PubMed: 9753063xa0 |
| Storage Conditions： | liquid nitrogen vapor phase |
| Images： | |
| Derivation： | The JeKo-1 Mantle cell lymphoma (MCL) cell line was established from peripheral blood mononuclear cells of a patient with a large cell variant of MCL showing leukemic conversion. |
| Clinical Data： | female The JeKo-1 Mantle cell lymphoma (MCL) cell line was established from peripheral blood mononuclear cells of a patient with a large cell variant of MCL showing leukemic conversion. |
| Antigen Expression： | CD3-, CD5+, CD10+, CD19+ (verified at ATCC) |
| Genes Expressed： | CD3-, CD5+, CD10+, CD19+ (verified at ATCC) |
| Comments： | The cells overexpress cyclin D1, Bcl-2, c-Myc and Rb proteins. Bcl-1/J(H) gene rearrangement was confirmed by polymerase chain reaction. JeKo-1 cells are highly tumorigenic in SCID mice. Ref
Jeon, H.J., et al. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol. ;102(5):1323-1326 (1998 ). PubMed: 9753063xa0JeKo-1 cells are negative for Epstein-Barr virus and express IgM, a B-cell phenotype.
|
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 20%.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 x 104 to 4 X 104 viable cells/mL. Do not allow the cell concentration to reach 2.5 X 106 cells/mL. |
| Cryopreservation： | Freeze medium: 30% RPMI; 60% FBS; 10% DMSO Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions： | Atmosphere: 5% CO2 in air recommended Temperature: 37°C |
| STR Profile： | Amelogenin:X CSF1PO:9,12 D13S317:8,9 D16S539:12 D5S818:10,13 D7S820:10,11 THO1:7 TPOX:8 vWA: 14 |
| Name of Depositor： | E Campo |
| References： | Salaverria I, et al. Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 91: 11-16, 2006. PubMed: 16434365 Camps, J., et al. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res. 30(8):923-934 (2006). PubMed: 16448697 Jeon, H.J., et al. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol. ;102(5):1323-1326 (1998 ). PubMed: 9753063 |
